Quite Effective: Rituxan (rituximab) (a monoclonal antibody against b-cells) is approved by the fda for treatment of patients with wegener's granulomatosis and microscopic polyangiitis and has a complete remission rate of about 64% after 6 months of therapy together with steroids. It works just as well as Cytoxan chemotherapy, the standard treatment it was compared to, with no major differences in overall side effects
Answered 7/1/2014
5.8k views
A doctor has provided 1 answer
A doctor has provided 1 answer
A doctor has provided 1 answer
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question